GRFS Grifols SA ADRs

Grifols SA is a pharmaceutical company. It primarily collects the liquid portion of human blood called plasma and then manufactures and sells plasma-derived products globally. It also operates diagnostics, hospital supplies, and raw materials businesses. This is an ADR of a company whose stock trades outside of the U.S. as the symbol SM:GRF.P .

$17.51  +0.17 (0.98%)
As of 06/24/2021 15:59:45 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  ADRs
Category3:  Mid cap
GICS sector:  Health Care
Industry:  Drug Manufacturers—General
Index country:  Spain
Country of incorporation:  Spain
IPO date:  06/02/2011
Outstanding shares:  261,425,000
Average volume:  747,269
Market cap:   $4,593,237,250
Current dividend yield:  2.60%
All SEC filings:   SEC Edgar Online
Annual filings:      20-F
CUSIP:    398438408
ISIN:        US3984384087
Sedol:      B8K7T65
Valuation   (See tab for details)
PE ratio:   35.46
PB ratio:   4.37
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy